Type I Interferons vs placebo
Serious adverse events · patients with induction of remission in ulcerative colitis
Type I Interferons showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
- Type I interferons for induction of remission in ulcerative colitis 2015 · Cochrane Headline outcomes onlyRR 0.74 [0.13, 4.14]4 studies · 468 participantsLow